OBJECTIVE: To critically re-evaluate cases diagnosed as adult neuronal ceroid lipofuscinosis (ANCL) in order to aid clinicopathologic diagnosis as a route to further gene discovery. METHODS: Through establishment of an international consortium we pooled 47 unsolved cases regarded by referring centers as ANCL. Clinical and neuropathologic experts within the Consortium established diagnostic criteria for ANCL based on the literature to assess each case. A panel of 3 neuropathologists independently reviewed source pathologic data. Cases were given a final clinicopathologic classification of definite ANCL, probable ANCL, possible ANCL, or not ANCL. RESULTS: Of the 47 cases, only 16 fulfilled the Consortium's criteria of ANCL (5 definite, 2 probable, 9 possible). Definitive alternate diagnoses were made in 10, including Huntington disease, early-onset Alzheimer disease, Niemann-Pick disease, neuroserpinopathy, prion disease, and neurodegeneration with brain iron accumulation. Six cases had features suggesting an alternate diagnosis, but no specific condition was identified; in 15, the data were inadequate for classification. Misinterpretation of normal lipofuscin as abnormal storage material was the commonest cause of misdiagnosis. CONCLUSIONS: Diagnosis of ANCL remains challenging; expert pathologic analysis and recent molecular genetic advances revealed misdiagnoses in >1/3 of cases. We now have a refined group of cases that will facilitate identification of new causative genes.

From the Epilepsy Research Centre Department of Medicine Department of Genetics Evolution and Environment and UCL Institute of Child Health University College London UK

Zobrazit více v PubMed

Mole SE, Williams RE, Goebel HH. The Neuronal Ceroid Lipofuscinoses (Batten Disease). 2nd ed. Oxford: Oxford University Press; 2011.

Palmer DN, Barry LA, Tyynela J, Cooper JD. NCL disease mechanisms. Biochim Biophys Acta 2013;1832:1882–1893. PubMed

Kousi M, Lehesjoki AE, Mole SE. Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Hum Mutat 2012;33:42–63. PubMed

Mole SE. NCL Mutation and Patient Database [online]. Available at: http://www.ucl.ac.uk/ncl/mutation.shtml. Accessed November 1, 2015.

Kmoch S, Stranecky V, Emes RD, Mitchison HM. Bioinformatic perspectives in the neuronal ceroid lipofuscinoses. Biochim Biophys Acta 2013;1832:1831–1841. PubMed

Berkovic SF, Carpenter S, Andermann F, et al. . Kufs' disease: a critical reappraisal. Brain 1988;111:27–62. PubMed

Anderson G, Elleder M, Goebel HH. Morphological diagnostic and pathological considerations. In: Mole SE, Williams RE, Goebel HH, eds. The Neuronal Ceroid Lipofuscinoses (Batten Disease). 2nd ed. Oxford: Oxford University Press; 2011:35–49.

Anderson GW, Goebel HH, Simonati A. Human pathology in NCL. Biochim Biophys Acta 2013;1832:1807–1826. PubMed

Carpenter S. Morphological diagnosis and misdiagnosis in Batten-Kufs disease. Am J Med Genet Suppl 1988;5:85–91. PubMed

Goebel HH, Braak H. Adult neuronal ceroid-lipofuscinosis. Clin Neuropathol 1989;8:109–119. PubMed

Goebel HH, Sharp JD. The neuronal ceroid-lipofuscinoses: recent advances. Brain Pathol 1998;8:151–162. PubMed PMC

Pasquinelli G, Cenacchi G, Piane EL, et al. . The problematic issue of Kufs disease diagnosis as performed on rectal biopsies: a case report. Ultrastruct Pathol 2004;28:43–48. PubMed

Sadzot B, Reznik M, Arrese-Estrada JE, Franck G. Familial Kufs' disease presenting as a progressive myoclonic epilepsy. J Neurol 2000;247:447–454. PubMed

Arsov T, Smith KR, Damiano J, et al. . Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6. Am J Hum Genet 2011;88:566–573. PubMed PMC

Andrade DM, Paton T, Turnbull J, et al. . Mutation of the CLN6 gene in teenage-onset progressive myoclonus epilepsy. Pediatr Neurol 2012;47:205–208. PubMed

Canafoglia L, Gilioli I, Invernizzi F, et al. . Electroclinical spectrum of the neuronal ceroid lipofuscinoses associated with CLN6 mutations. Neurology 2015;85:316–324. PubMed PMC

Cadieux-Dion M, Andermann E, Lachance-Touchette P, et al. . Recurrent mutations in DNAJC5 cause autosomal dominant Kufs disease. Clin Genet 2013;83:571–575. PubMed

Noskova L, Stranecky V, Hartmannova H, et al. . Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis. Am J Hum Genet 2011;89:241–252. PubMed PMC

Velinov M, Dolzhanskaya N, Gonzalez M, et al. . Mutations in the gene DNAJC5 cause autosomal dominant Kufs disease in a proportion of cases: study of the Parry family and 8 other families. PLoS One 2012;7:e29729. PubMed PMC

Smith KR, Dahl HH, Canafoglia L, et al. . Cathepsin F mutations cause type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis. Hum Mol Genet 2013;22:1417–1423. PubMed PMC

Di Fabio R, Moro F, Pestillo L, et al. . Pseudo-dominant inheritance of a novel CTSF mutation associated with type B Kufs disease. Neurology 2014;83:1769–1770. PubMed

van Diggelen OP, Thobois S, Tilikete C, et al. . Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease. Ann Neurol 2001;50:269–272. PubMed

Ramadan H, Al-Din AS, Ismail A, et al. . Adult neuronal ceroid lipofuscinosis caused by deficiency in palmitoyl protein thioesterase 1. Neurology 2007;68:387–388. PubMed

Sleat DE, Ding L, Wang S, et al. . Mass spectrometry-based protein profiling to determine the cause of lysosomal storage diseases of unknown etiology. Mol Cell Proteomics 2009;8:1708–1718. PubMed PMC

Xin W, Mullen TE, Kiely R, et al. . CLN5 mutations are frequent in juvenile and late-onset non-Finnish patients with NCL. Neurology 2010;74:565–571. PubMed

Smith KR, Damiano J, Franceschetti S, et al. . Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. Am J Hum Genet 2012;90:1102–1107. PubMed PMC

Lauronen L, Munroe PB, Jarvela I, et al. . Delayed classic and protracted phenotypes of compound heterozygous juvenile neuronal ceroid lipofuscinosis. Neurology 1999;52:360–365. PubMed

Park EJ, Grabinska KA, Guan Z, et al. . Mutation of Nogo-B receptor, a subunit of cis-prenyltransferase, causes a congenital disorder of glycosylation. Cell Metab 2014;20:448–457. PubMed PMC

Reif A, Schneider MF, Hoyer A, et al. . Neuroleptic malignant syndrome in Kufs' disease. J Neurol Neurosurg Psychiatry 2003;74:385–387. PubMed PMC

Zini A, Cenacchi G, Nichelli P, et al. . Early-onset dementia with prolonged occipital seizures: an atypical case of Kufs disease. Neurology 2008;71:1709–1712. PubMed

Carpenter S, Karpati G, Andermann F, et al. . The ultrastructural characteristics of the abnormal cytosomes in Batten-Kufs' disease. Brain 1977;100:137–156. PubMed

Boehme DH, Cottrell JC, Leonberg SC, Zeman W. A dominant form of neuronal ceroid-lipofuscinosis. Brain 1971;94:745–760. PubMed

Burneo JG, Arnold T, Palmer CA, Kuzniecky RI, Oh SJ, Faught E. Adult-onset neuronal ceroid lipofuscinosis (Kufs disease) with autosomal dominant inheritance in Alabama. Epilepsia 2003;44:841–846. PubMed

Williams RE, Mole SE. New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses. Neurology 2012;79:183–191. PubMed

Ferlazzo E, Gasparini S, Pasquinelli G, et al. . Usefulness of rectal biopsy for the diagnosis of Kufs disease: a controlled study and review of the literature. Eur J Neurol 2012;19:1331–1336. PubMed

Muona M, Berkovic SF, Dibbens LM, et al. . A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy. Nat Genet 2015;47:39–46. PubMed PMC

Ehling R, Nosková L, Stranecký V, et al. . Cerebellar dysfunction in a family harboring the PSEN1 mutation co-segregating with a cathepsin D variant p.A58V. J Neurol Sci 2013;326:75–82. PubMed

Autosomal-dominant adult neuronal ceroid lipofuscinosis caused by duplication in DNAJC5 initially missed by Sanger and whole-exome sequencing